Bajaj Consumer Care Limited (BAJAJCON.BO)
INR 170.35
(-2.85%)
INR 170.35
(-2.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.99 Billion INR | -13.64% |
| 2022 | 1.78 Billion INR | -14.27% |
| 2021 | 2.12 Billion INR | -24.03% |
| 2020 | 2.77 Billion INR | 18.15% |
| 2019 | 2.35 Billion INR | -21.51% |
| 2018 | 2.91 Billion INR | 5.8% |
| 2017 | 2.78 Billion INR | -3.55% |
| 2016 | 2.84 Billion INR | -2.38% |
| 2015 | 2.55 Billion INR | 12.99% |
| 2014 | 2.23 Billion INR | 20.82% |
| 2013 | 1.91 Billion INR | 6.01% |
| 2012 | 2.12 Billion INR | 37.33% |
| 2011 | 1.53 Billion INR | 19.51% |
| 2010 | 1.25 Billion INR | 22.89% |
| 2009 | 1.02 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 366.26 Million INR | 2.68% |
| 2023 Q1 | 584.28 Million INR | 13.08% |
| 2023 Q4 | 347.11 Million INR | -26.24% |
| 2023 Q2 | 480.88 Million INR | -17.7% |
| 2023 Q3 | 470.62 Million INR | -2.13% |
| 2023 FY | - INR | -13.64% |
| 2022 FY | - INR | -14.27% |
| 2022 Q1 | 431.47 Million INR | -4.63% |
| 2022 Q2 | 405.14 Million INR | -6.1% |
| 2022 Q3 | 428.22 Million INR | 5.7% |
| 2022 Q4 | 516.68 Million INR | 20.66% |
| 2021 Q1 | 607.59 Million INR | -10.41% |
| 2021 FY | - INR | -24.03% |
| 2021 Q4 | 452.4 Million INR | -6.12% |
| 2021 Q3 | 481.91 Million INR | -17.23% |
| 2021 Q2 | 582.24 Million INR | -4.17% |
| 2020 Q1 | 676.06 Million INR | 120.5% |
| 2020 Q3 | 715.28 Million INR | 0.93% |
| 2020 FY | - INR | 18.15% |
| 2020 Q2 | 708.69 Million INR | 4.83% |
| 2020 Q4 | 678.22 Million INR | -5.18% |
| 2019 FY | - INR | -21.51% |
| 2019 Q1 | 745.86 Million INR | -5.07% |
| 2019 Q3 | 620.42 Million INR | -8.17% |
| 2019 Q2 | 675.64 Million INR | -9.41% |
| 2019 Q4 | 306.6 Million INR | -50.58% |
| 2018 FY | - INR | 5.8% |
| 2018 Q4 | 785.65 Million INR | 1.2% |
| 2018 Q3 | 776.34 Million INR | 16.9% |
| 2018 Q2 | 664.09 Million INR | -3.21% |
| 2018 Q1 | 686.13 Million INR | 0.0% |
| 2017 FY | - INR | -3.55% |
| 2016 FY | - INR | -2.38% |
| 2015 FY | - INR | 12.99% |
| 2014 FY | - INR | 20.82% |
| 2013 FY | - INR | 6.01% |
| 2013 Q3 | - INR | 0.0% |
| 2012 FY | - INR | 37.33% |
| 2012 Q3 | - INR | 0.0% |
| 2011 FY | - INR | 19.51% |
| 2010 FY | - INR | 22.89% |
| 2009 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ador Multiproducts Limited | -24.81 Million INR | 8159.213% |
| Ambica Agarbathies Aroma & Industries Limited | 98.85 Million INR | -1922.888% |
| Colgate-Palmolive (India) Limited | 19.57 Billion INR | 89.786% |
| Cupid Limited | 501.01 Million INR | -299.129% |
| Dabur India Limited | 28.81 Billion INR | 93.06% |
| Emami Limited | 9.9 Billion INR | 79.81% |
| Gillette India Limited | 6.27 Billion INR | 68.128% |
| Godrej Consumer Products Limited | 7.23 Billion INR | 72.368% |
| Hindustan Unilever Limited | 152.56 Billion INR | 98.689% |
| Hipolin Limited | -7.05 Million INR | 28452.261% |
| Honasa Consumer Limited | 1.86 Billion INR | -7.056% |
| JHS Svendgaard Laboratories Limited | 33.77 Million INR | -5820.432% |
| Jyothy Labs Limited | 5.33 Billion INR | 62.52% |
| Kaya Limited | -233.46 Million INR | 956.543% |
| Marico Limited | 21.67 Billion INR | 90.772% |
| N.K Industries Limited | 19.9 Million INR | -9947.659% |
| PAOS INDUSTRIES LIMITED | 1000.00 INR | -199968400.0% |
| Paramount Cosmetics (India) Limited | 4.5 Million INR | -44337.444% |
| Pee Cee Cosma Sope Limited | 159.57 Million INR | -1153.108% |
| Procter & Gamble Hygiene and Health Care Limited | 9.83 Billion INR | 79.663% |